Fig. 3.

Anti-CD20 therapy does not affect anti-tumor immune responses in murine melanoma (YUMMER1.7). a Survival of YUMMER1.7 tumor bearing mice treated with saline (ctrl), anti-CD20, anti-PD-1, or anti-CD20 + anti-PD-1 (comb), n = 10. Ctrl vs CD20 p = 0.08; PD-1 vs comb p = 0.73; ctrl vs comb p = 0.0008. b Waterfall plot of groups in a, shown as percent change in tumor size relative to size at day 10